 | • レポートコード：MRC2-11QY07588 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメラノコルチン受容体4のグローバル市場について調査・分析したレポートです。種類別（ブレメラノチド、コルチコトロピン、コシントロピン、その他）市場規模、用途別（代謝障害、女性健康、泌尿生殖器系、感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メラノコルチン受容体4の競争状況、市場シェア ・世界のメラノコルチン受容体4市場：種類別市場規模 2015年-2020年（ブレメラノチド、コルチコトロピン、コシントロピン、その他） ・世界のメラノコルチン受容体4市場：種類別市場規模予測 2021年-2026年（ブレメラノチド、コルチコトロピン、コシントロピン、その他） ・世界のメラノコルチン受容体4市場：用途別市場規模 2015年-2020年（代謝障害、女性健康、泌尿生殖器系、感染症、その他） ・世界のメラノコルチン受容体4市場：用途別市場規模予測 2021年-2026年（代謝障害、女性健康、泌尿生殖器系、感染症、その他） ・北米のメラノコルチン受容体4市場分析：米国、カナダ ・ヨーロッパのメラノコルチン受容体4市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメラノコルチン受容体4市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメラノコルチン受容体4市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメラノコルチン受容体4市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca Plc、Mallinckrodt Plc、Obexia AG、Palatin Technologies, Inc.、Pfizer Inc.、Retrophin Inc.、Rhythm Pharmaceuticals, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Melanocortin Receptor 4 Market
The global Melanocortin Receptor 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Melanocortin Receptor 4 Scope and Market Size
Melanocortin Receptor 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Melanocortin Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Melanocortin Receptor 4 market is segmented into
Bremelanotide
Corticotropin
Cosyntropin
Others
Segment by Application, the Melanocortin Receptor 4 market is segmented into
Metabolic Disorder
Women’s Health
Genito Urinary System
Infection Disease
Others
Regional and Country-level Analysis
The Melanocortin Receptor 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Melanocortin Receptor 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Melanocortin Receptor 4 Market Share Analysis
Melanocortin Receptor 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Melanocortin Receptor 4 business, the date to enter into the Melanocortin Receptor 4 market, Melanocortin Receptor 4 product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
Mallinckrodt Plc
Obexia AG
Palatin Technologies, Inc.
Pfizer Inc.
Retrophin Inc.
Rhythm Pharmaceuticals, Inc.
…
1 Study Coverage
1.1 Melanocortin Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Melanocortin Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Type
1.4.2 Bremelanotide
1.4.3 Corticotropin
1.4.4 Cosyntropin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Application
1.5.2 Metabolic Disorder
1.5.3 Women’s Health
1.5.4 Genito Urinary System
1.5.5 Infection Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Melanocortin Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Melanocortin Receptor 4 Revenue 2015-2026
2.1.2 Global Melanocortin Receptor 4 Sales 2015-2026
2.2 Global Melanocortin Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Melanocortin Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Melanocortin Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Melanocortin Receptor 4 Competitor Landscape by Players
3.1 Melanocortin Receptor 4 Sales by Manufacturers
3.1.1 Melanocortin Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Melanocortin Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Melanocortin Receptor 4 Revenue by Manufacturers
3.2.1 Melanocortin Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Melanocortin Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Melanocortin Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Melanocortin Receptor 4 Revenue in 2019
3.2.5 Global Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Melanocortin Receptor 4 Price by Manufacturers
3.4 Melanocortin Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Melanocortin Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Melanocortin Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Melanocortin Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Melanocortin Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Melanocortin Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Melanocortin Receptor 4 Revenue by Type (2015-2020)
4.1.3 Melanocortin Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Melanocortin Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Melanocortin Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Melanocortin Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Melanocortin Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Melanocortin Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Melanocortin Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Melanocortin Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Melanocortin Receptor 4 Revenue by Application (2015-2020)
5.1.3 Melanocortin Receptor 4 Price by Application (2015-2020)
5.2 Melanocortin Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Melanocortin Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Melanocortin Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Melanocortin Receptor 4 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Melanocortin Receptor 4 by Country
6.1.1 North America Melanocortin Receptor 4 Sales by Country
6.1.2 North America Melanocortin Receptor 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Melanocortin Receptor 4 Market Facts & Figures by Type
6.3 North America Melanocortin Receptor 4 Market Facts & Figures by Application
7 Europe
7.1 Europe Melanocortin Receptor 4 by Country
7.1.1 Europe Melanocortin Receptor 4 Sales by Country
7.1.2 Europe Melanocortin Receptor 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Melanocortin Receptor 4 Market Facts & Figures by Type
7.3 Europe Melanocortin Receptor 4 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Melanocortin Receptor 4 by Region
8.1.1 Asia Pacific Melanocortin Receptor 4 Sales by Region
8.1.2 Asia Pacific Melanocortin Receptor 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Melanocortin Receptor 4 Market Facts & Figures by Type
8.3 Asia Pacific Melanocortin Receptor 4 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Melanocortin Receptor 4 by Country
9.1.1 Latin America Melanocortin Receptor 4 Sales by Country
9.1.2 Latin America Melanocortin Receptor 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Melanocortin Receptor 4 Market Facts & Figures by Type
9.3 Central & South America Melanocortin Receptor 4 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Melanocortin Receptor 4 by Country
10.1.1 Middle East and Africa Melanocortin Receptor 4 Sales by Country
10.1.2 Middle East and Africa Melanocortin Receptor 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Melanocortin Receptor 4 Market Facts & Figures by Type
10.3 Middle East and Africa Melanocortin Receptor 4 Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Melanocortin Receptor 4 Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.2 Mallinckrodt Plc
11.2.1 Mallinckrodt Plc Corporation Information
11.2.2 Mallinckrodt Plc Description and Business Overview
11.2.3 Mallinckrodt Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mallinckrodt Plc Melanocortin Receptor 4 Products Offered
11.2.5 Mallinckrodt Plc Related Developments
11.3 Obexia AG
11.3.1 Obexia AG Corporation Information
11.3.2 Obexia AG Description and Business Overview
11.3.3 Obexia AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Obexia AG Melanocortin Receptor 4 Products Offered
11.3.5 Obexia AG Related Developments
11.4 Palatin Technologies, Inc.
11.4.1 Palatin Technologies, Inc. Corporation Information
11.4.2 Palatin Technologies, Inc. Description and Business Overview
11.4.3 Palatin Technologies, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Palatin Technologies, Inc. Melanocortin Receptor 4 Products Offered
11.4.5 Palatin Technologies, Inc. Related Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Corporation Information
11.5.2 Pfizer Inc. Description and Business Overview
11.5.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Inc. Melanocortin Receptor 4 Products Offered
11.5.5 Pfizer Inc. Related Developments
11.6 Retrophin Inc.
11.6.1 Retrophin Inc. Corporation Information
11.6.2 Retrophin Inc. Description and Business Overview
11.6.3 Retrophin Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Retrophin Inc. Melanocortin Receptor 4 Products Offered
11.6.5 Retrophin Inc. Related Developments
11.7 Rhythm Pharmaceuticals, Inc.
11.7.1 Rhythm Pharmaceuticals, Inc. Corporation Information
11.7.2 Rhythm Pharmaceuticals, Inc. Description and Business Overview
11.7.3 Rhythm Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Products Offered
11.7.5 Rhythm Pharmaceuticals, Inc. Related Developments
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Melanocortin Receptor 4 Products Offered
11.1.5 AstraZeneca Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Melanocortin Receptor 4 Market Estimates and Projections by Region
12.1.1 Global Melanocortin Receptor 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Melanocortin Receptor 4 Revenue Forecast by Regions 2021-2026
12.2 North America Melanocortin Receptor 4 Market Size Forecast (2021-2026)
12.2.1 North America: Melanocortin Receptor 4 Sales Forecast (2021-2026)
12.2.2 North America: Melanocortin Receptor 4 Revenue Forecast (2021-2026)
12.2.3 North America: Melanocortin Receptor 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Melanocortin Receptor 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Melanocortin Receptor 4 Sales Forecast (2021-2026)
12.3.2 Europe: Melanocortin Receptor 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Melanocortin Receptor 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Melanocortin Receptor 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Melanocortin Receptor 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Melanocortin Receptor 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Melanocortin Receptor 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Melanocortin Receptor 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Melanocortin Receptor 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Melanocortin Receptor 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Melanocortin Receptor 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Melanocortin Receptor 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Melanocortin Receptor 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Melanocortin Receptor 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Melanocortin Receptor 4 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Melanocortin Receptor 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Melanocortin Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Melanocortin Receptor 4 Market Segments
Table 2. Ranking of Global Top Melanocortin Receptor 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Melanocortin Receptor 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Bremelanotide
Table 5. Major Manufacturers of Corticotropin
Table 6. Major Manufacturers of Cosyntropin
Table 7. Major Manufacturers of Others
Table 8. Global Melanocortin Receptor 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Melanocortin Receptor 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Melanocortin Receptor 4 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Melanocortin Receptor 4 Sales Market Share by Regions (2015-2020)
Table 12. Global Melanocortin Receptor 4 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Melanocortin Receptor 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Melanocortin Receptor 4 Sales Share by Manufacturers (2015-2020)
Table 15. Global Melanocortin Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Melanocortin Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanocortin Receptor 4 as of 2019)
Table 17. Melanocortin Receptor 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Melanocortin Receptor 4 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Melanocortin Receptor 4 Price (2015-2020) (USD/Pcs)
Table 20. Melanocortin Receptor 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Melanocortin Receptor 4 Product Type
Table 22. Date of International Manufacturers Enter into Melanocortin Receptor 4 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Melanocortin Receptor 4 Sales Share by Type (2015-2020)
Table 26. Global Melanocortin Receptor 4 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Melanocortin Receptor 4 Revenue Share by Type (2015-2020)
Table 28. Melanocortin Receptor 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Melanocortin Receptor 4 Sales Share by Application (2015-2020)
Table 31. North America Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 33. North America Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 35. North America Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Table 37. North America Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Table 39. Europe Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 41. Europe Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 43. Europe Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Table 45. Europe Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Melanocortin Receptor 4 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Melanocortin Receptor 4 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Melanocortin Receptor 4 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Table 55. Latin America Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Table 61. Latin America Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Table 71. AstraZeneca Plc Corporation Information
Table 72. AstraZeneca Plc Description and Major Businesses
Table 73. AstraZeneca Plc Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. AstraZeneca Plc Product
Table 75. AstraZeneca Plc Recent Development
Table 76. Mallinckrodt Plc Corporation Information
Table 77. Mallinckrodt Plc Description and Major Businesses
Table 78. Mallinckrodt Plc Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Mallinckrodt Plc Product
Table 80. Mallinckrodt Plc Recent Development
Table 81. Obexia AG Corporation Information
Table 82. Obexia AG Description and Major Businesses
Table 83. Obexia AG Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Obexia AG Product
Table 85. Obexia AG Recent Development
Table 86. Palatin Technologies, Inc. Corporation Information
Table 87. Palatin Technologies, Inc. Description and Major Businesses
Table 88. Palatin Technologies, Inc. Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Palatin Technologies, Inc. Product
Table 90. Palatin Technologies, Inc. Recent Development
Table 91. Pfizer Inc. Corporation Information
Table 92. Pfizer Inc. Description and Major Businesses
Table 93. Pfizer Inc. Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Pfizer Inc. Product
Table 95. Pfizer Inc. Recent Development
Table 96. Retrophin Inc. Corporation Information
Table 97. Retrophin Inc. Description and Major Businesses
Table 98. Retrophin Inc. Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Retrophin Inc. Product
Table 100. Retrophin Inc. Recent Development
Table 101. Rhythm Pharmaceuticals, Inc. Corporation Information
Table 102. Rhythm Pharmaceuticals, Inc. Description and Major Businesses
Table 103. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Rhythm Pharmaceuticals, Inc. Product
Table 105. Rhythm Pharmaceuticals, Inc. Recent Development
Table 106. Global Melanocortin Receptor 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 107. Global Melanocortin Receptor 4 Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Melanocortin Receptor 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Melanocortin Receptor 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Melanocortin Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. North America: Melanocortin Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Melanocortin Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Europe: Melanocortin Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Melanocortin Receptor 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 115. Asia Pacific: Melanocortin Receptor 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Melanocortin Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Latin America: Melanocortin Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Melanocortin Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Middle East and Africa: Melanocortin Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Melanocortin Receptor 4 Players
Table 124. Melanocortin Receptor 4 Customers List
Table 125. Melanocortin Receptor 4 Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Melanocortin Receptor 4 Product Picture
Figure 2. Global Melanocortin Receptor 4 Sales Market Share by Type in 2020 & 2026
Figure 3. Bremelanotide Product Picture
Figure 4. Corticotropin Product Picture
Figure 5. Cosyntropin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Melanocortin Receptor 4 Sales Market Share by Application in 2020 & 2026
Figure 8. Metabolic Disorder
Figure 9. Women's Health
Figure 10. Genito Urinary System
Figure 11. Infection Disease
Figure 12. Others
Figure 13. Melanocortin Receptor 4 Report Years Considered
Figure 14. Global Melanocortin Receptor 4 Market Size 2015-2026 (US$ Million)
Figure 15. Global Melanocortin Receptor 4 Sales 2015-2026 (K Pcs)
Figure 16. Global Melanocortin Receptor 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Melanocortin Receptor 4 Sales Market Share by Region (2015-2020)
Figure 18. Global Melanocortin Receptor 4 Sales Market Share by Region in 2019
Figure 19. Global Melanocortin Receptor 4 Revenue Market Share by Region (2015-2020)
Figure 20. Global Melanocortin Receptor 4 Revenue Market Share by Region in 2019
Figure 21. Global Melanocortin Receptor 4 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Melanocortin Receptor 4 Revenue in 2019
Figure 23. Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Figure 25. Global Melanocortin Receptor 4 Sales Market Share by Type in 2019
Figure 26. Global Melanocortin Receptor 4 Revenue Market Share by Type (2015-2020)
Figure 27. Global Melanocortin Receptor 4 Revenue Market Share by Type in 2019
Figure 28. Global Melanocortin Receptor 4 Market Share by Price Range (2015-2020)
Figure 29. Global Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Figure 30. Global Melanocortin Receptor 4 Sales Market Share by Application in 2019
Figure 31. Global Melanocortin Receptor 4 Revenue Market Share by Application (2015-2020)
Figure 32. Global Melanocortin Receptor 4 Revenue Market Share by Application in 2019
Figure 33. North America Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 36. North America Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 37. U.S. Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Melanocortin Receptor 4 Market Share by Type in 2019
Figure 42. North America Melanocortin Receptor 4 Market Share by Application in 2019
Figure 43. Europe Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 46. Europe Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 47. Germany Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Melanocortin Receptor 4 Market Share by Type in 2019
Figure 58. Europe Melanocortin Receptor 4 Market Share by Application in 2019
Figure 59. Asia Pacific Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Melanocortin Receptor 4 Revenue Market Share by Region in 2019
Figure 63. China Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Melanocortin Receptor 4 Market Share by Type in 2019
Figure 86. Asia Pacific Melanocortin Receptor 4 Market Share by Application in 2019
Figure 87. Latin America Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 90. Latin America Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 91. Mexico Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Melanocortin Receptor 4 Market Share by Type in 2019
Figure 98. Latin America Melanocortin Receptor 4 Market Share by Application in 2019
Figure 99. Middle East and Africa Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 103. Turkey Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Melanocortin Receptor 4 Market Share by Type in 2019
Figure 110. Middle East and Africa Melanocortin Receptor 4 Market Share by Application in 2019
Figure 111. North America Melanocortin Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Melanocortin Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Melanocortin Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Melanocortin Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Melanocortin Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Melanocortin Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Melanocortin Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Melanocortin Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Melanocortin Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Melanocortin Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
副腎皮質刺激ホルモン受容体の世界市場（～2026年） Market Analysis and Insights: Global Adrenocorticotropic Hormone Receptor Market The global Adrenocorticotropic Hormone Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adrenocorticotropic Hormone Receptor Scop…- アルファ2Cアドレナリン受容体の世界市場（～2026年） Market Analysis and Insights: Global Alpha 2C Adrenergic Receptor Market The global Alpha 2C Adrenergic Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha 2C Adrenergic Receptor Scope and Market Size Alpha …
- アンジオテンシンII受容体の世界市場（～2026年） Market Analysis and Insights: Global Angiotensin II Receptor Market The global Angiotensin II Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Angiotensin II Receptor Scope and Market Size Angiotensin II Recept…
- ソマトスタチン受容体2型の世界市場（～2026年） Market Analysis and Insights: Global Somatostatin Receptor Type 2 Market The global Somatostatin Receptor Type 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Somatostatin Receptor Type 2 Scope and Market Size Somato…
- エストロゲン受容体ベータの世界市場（～2026年） Market Analysis and Insights: Global Estrogen Receptor Beta Market The global Estrogen Receptor Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Estrogen Receptor Beta Scope and Market Size Estrogen Receptor Beta m…